Impairment of ultrastructure and cytoskeleton during progression of cardiac hypertrophy to heart failure

Laboratory Investigation

Volumn 90, Issue 4, 2010, Pages 520-530

  Gupta, Anasuya ^a   Gupta, Sudhiranjan ^a   Young, David ^a   Das, Biswajit ^a   McMahon, James ^a   Sen, Subha ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiomyopathy; Desmin; Myocytes; Myotrophin; Transgenic mice; Tubulin

Indexed keywords

DESMIN; MYELIN; TUBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CELL NUCLEUS MEMBRANE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOARCHITECTURE; CYTOSKELETON; DISEASE COURSE; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MITOCHONDRION SWELLING; MOUSE; MUSCLE FIBRIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; CARDIOMEGALY; DESMIN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HEART FAILURE; HEART VENTRICLES; MICE; MICE, TRANSGENIC; MITOCHONDRIA, HEART; MYOCARDIUM; MYOCYTES, CARDIAC; MYOFIBRILS; TUBULIN;

EID: 77950363582     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.43     Document Type: Article

References (27)

1. Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress. Circulation 2000;102(20 Suppl 4):IV14-IV23.
2. Hunter JJ, Chien KR. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 1999;341:1276-1283.
3. Ritter O, Neyses L. The molecular basis of myocardial hypertrophy and heart failure. Trends Mol Med 2003;9:313-321.
4. Baba HA, Takeda A, Nagano M. The influence of decreased left-ventricular afterload on cardiac morphology in hypertrophied rat hearts. Int J Cardiol 1995;49:107-117.
5. Vetterlein F, Schrader C, Volkmann R, et al. Extent of damage in ischemic, nonreperfused, and reperfused myocardium of anesthetized rats. Am J Physiol Heart Circ Physiol 2003;285:H755-H765. E-pub 1 May 2003.
6. Hein S, Arnon E, Kostin S, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003;107:984-991.
7. Schaper J, Froede R, Hein S, et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 1991;83:504-514.
8. Capasso JM, Palackal T, Olivetti G, et al. Left ventricular failure induced by longterm hypertension in rats. Circ Res 1990;66:1400-1412.
9. Weber KT. Targeting pathological remodeling: concepts of cardioprotection and reparation. Circulation 2000;102:1342-1345.
10. Frerichs FC, Dingemans KP, Brinkman K. Cardiomyopathy with mitochondrial damage associated with nucleoside reverse-transcriptase inhibitors. N Engl J Med 2002;347:1895-1896.
11. Molnar M, Schröder JM. Pleomorphic mitochondrial and different filamentous inclusions in inflammatory myopathies associated with mtDNA deletions. Acta Neuropathol (Berl) 1998;96:41-51.
12. Li YY, McTiernan CF, Feldman AM. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 2000;46: 214-224.
13. Wang J, Xu N, Feng X, et al. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure. Circ Res 2005;97:821-828. E-pub 8 September 2005.
14. Sivasubramanian N, Coker ML, Kurrelmeyer KM, et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2001;104:826-831.
15. Sarkar S, Leaman DW, Gupta S, et al. Cardiac expression of myotrophin triggers myocardial hypertrophy and heart failure in transgenic mice. J Biol Chem 2004;279:20422-20434. E-pub 16 February 2004.
16. Kostin S, Hein S, Arnon E, et al. The cytoskeleton and related protein in human heart. Heart Fail Rev 2000;5:271-280.
17. Pereira LM, Mandarim-De-Lacerda CA. Quantitative examination of the cardiac myocytes in hypertensive rats under chronic inhibition of nitric oxide synthesis. J Biomed Sci 1998;5:363-369.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
19. Piper HM. Mitochondrial injury in the oxygen-depleted and reoxygenated myocardial cell. In: Piper HM (ed). Pathophysiology of Severe Ischemic Myocardial Injury. Kluwer Academic Publishers: Dordrecht, Boston, 1990, pp 91-113.
20. Dolman J, Godin DV. Myocardial ischaemic/reperfusion injury in the anaesthetized rabbit: comparative effects of halothane and isoflurane. Can Anaesth Soc J 1986;33:443-452.
21. Alexander CM, Werb Z. Proteinases and extracellular matrix remodeling. Curr Opin Cell Biol 1989;1:974-982.
22. Brilla CG, Rupp H. Myocardial collagen matrix remodeling and congestive heart failure. Cardiologia 1994;39(12 Suppl 1):389-393.
23. Nikolova V, Leimena C, McMahon AC, et al. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J Clin Invest 2004;113:357-369.
24. Ozisik K, Yildirim E, Kaplan S, et al. Ultrastructural changes of rat cardiac myocytes in a time-dependent manner after traumatic brain injury. Am J Transplant 2004;4:900-904. (Pubitemid 38745588) (Pubitemid 38745588)
25. Tokuyasu KT, Dutton AH, Singer SJ. Immunoelectron microscopic studies of desmin (skeletin) localization and intermediate filament organization in chicken cardiac muscle. J Cell Biol 1983;96:1736-1742.
26. Hein S, Kostin S, Heling A, et al. The role of the cytoskeleton in heart failure. Cardiovasc Res 2000;45:273-278.
27. Heling A, Zimmermann R, Kostin S, et al. Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res 2000;86:846-853.